Global Implantable Neurostimulation Devices Market Growth 2023-2029

Global Implantable Neurostimulation Devices Market Growth 2023-2029

Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

LPI (LP Information)' newest research report, the “Implantable Neurostimulation Devices Industry Forecast” looks at past sales and reviews total world Implantable Neurostimulation Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Implantable Neurostimulation Devices sales for 2023 through 2029. With Implantable Neurostimulation Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Neurostimulation Devices industry.

This Insight Report provides a comprehensive analysis of the global Implantable Neurostimulation Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Neurostimulation Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Implantable Neurostimulation Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Neurostimulation Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Neurostimulation Devices.

The global Implantable Neurostimulation Devices market size is projected to grow from US$ 6495.6 million in 2022 to US$ 14020 million in 2029; it is expected to grow at a CAGR of 14020 from 2023 to 2029.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Neurostimulation Devices market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Spinal Cord Stimulation (SCS)
Gastric Electric Stimulation (GES)
Deep Brain Stimulation (DBS)
Sacral Nerve Stimulation (SNS)
Vagus Nerve Stimulation (VNS)
Others

Segmentation by application
Pain Management
Parkinson's Disease
Urinary and Fecal Incontinence
Epilepsy
Gastroparesis
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
St. Jude Medical (Abbott)
LivaNova
Nevro
NeuroPace
Beijing Pins
Synapse Biomedical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Implantable Neurostimulation Devices market?

What factors are driving Implantable Neurostimulation Devices market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Implantable Neurostimulation Devices market opportunities vary by end market size?

How does Implantable Neurostimulation Devices break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.